Skip to main content
SpringerLink
Log in

Medical Management of Short Bowel Syndrome and Nutritional Support

  • Chapter
  • First Online:
Mesenteric Vascular Disease

  • 1697 Accesses

Abstract

Short bowel syndrome (SBS) manifests in patients surviving multiple intestinal resections following the ischemia. SBS patients can present with severe fluid, electrolyte, and vitamin deficiencies. There is no consensus in the literature for an accurate definition of SBS. It can be divided in three distinct clinical stages: early, intermediate, and late phase with management being distinctly different in each phase. Long-term survival depends on the remaining length of small bowel and degree of intestinal adaptation. Optimizing nutrition through dietary strategies, oral rehydration solutions, and long-term parenteral nutrition is necessary for achieving intestinal adaptation. Various pharmacological agents such as antidiarrheals, antisecretory, and growth factors provide a supporting role to slow down intestinal transit time and increase absorption.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sise MJ. Acute mesenteric ischemia. Surg Clin North Am. 2014;94(1):165–81 [Review].

    Article  PubMed  Google Scholar 

  2. Bobadilla JL. Mesenteric ischemia. Surg Clin North Am. 2013;93(4):925–40. ix. [Review].

    Article  PubMed  Google Scholar 

  3. Cudnik MT, Darbha S, Jones J, Macedo J, Hiestand BC, Stockton SW. The diagnosis of acute mesenteric ischemia: a systematic review and meta-analysis. Acad Emerg Med. 2013;20(11):1087–100.

    Article  PubMed  Google Scholar 

  4. DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 1. Am J Gastroenterol. 2004;99(7):1386–95 [Review].

    Article  PubMed  Google Scholar 

  5. Nightingale JM. Management of patients with a short bowel. World J Gastroenterol. 2001;7(6):741–51 [Review].

    CAS  PubMed  Google Scholar 

  6. Kelly DG, Tappenden KA, Winkler MF. Short Bowel Syndrome: highlights of patient management, quality of life, and survival. JPEN J Parenter Enteral Nutr. 2014;38(4):427–37.

    Article  PubMed  Google Scholar 

  7. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124(4):1111–34 [Research Support, Non-U.S. Gov’t Review].

    Article  PubMed  Google Scholar 

  8. Genton L, Nardo P, Huber O, Pichard C. Parenteral nutrition independence in a patient left with 25 cm of ileum and jejunum: a case report. Obes Surg. 2010;20(5):666–71 [Case Reports Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  9. O’Keefe SJ, Buchman AL, Fishbein TM, Jeejeebhoy KN, Jeppesen PB, Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006;4(1):6–10 [Consensus Development Conference Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  10. Hofmann AF, Borgstrom B. Hydrolysis of long-chain monoglycerides in micellar solution by pancreatic lipase. Biochim Biophys Acta. 1963;70:317–31.

    Article  CAS  PubMed  Google Scholar 

  11. Borgstrom B, Dahlqvist A, Lundh G, Sjovall J. Studies of intestinal digestion and absorption in the human. J Clin Invest. 1957;36(10):1521–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Jeong SH, Lee HJ, Bae HJ, Kim Y, Yoo MW, Yoon YK, et al. Factors affecting postoperative dietary adaptation in short bowel syndrome. Hepatogastroenterology. 2009;56(93):1049–52.

    PubMed  Google Scholar 

  13. Vanderhoof JA, Langnas AN. Short-bowel syndrome in children and adults. Gastroenterology. 1997;113(5):1767–78 [Review].

    Article  CAS  PubMed  Google Scholar 

  14. Buccigrossi V, Armellino C, Tozzi A, Nicastro E, Esposito C, Alicchio F, et al. Time- and segment-related changes of postresected intestine: a 4-dimensional model of intestinal adaptation. J Pediatr Gastroenterol Nutr. 2013;56(1):40–5 [Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  15. Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR, Bartram CI. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut. 1992;33(11):1493–7 [Comparative Study].

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Swaniker F, Guo W, Fonkalsrud EW, Brown T, Newman L, Ament M. Adaptation of rabbit small intestinal brush-border membrane enzymes after extensive bowel resection. J Pediatr Surg. 1995;30(7):1000–2. [Research Support, Non-U.S. Gov’t]; discussion 3.

    Article  CAS  PubMed  Google Scholar 

  17. Nakayama H, Weser E. Adaptation of small bowel after intestinal resection: increase in the pentose phosphate pathway. Biochim Biophys Acta. 1972;279(3):416–23.

    Article  CAS  PubMed  Google Scholar 

  18. Kander R. SBS diet needs to address individual physiology. J Am Diet Assoc. 1999;99(5):529–30 [Comment Letter].

    Article  CAS  PubMed  Google Scholar 

  19. Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci. 2003;8:e437–43 [Research Support, Non-U.S. Gov’t Review].

    Article  CAS  PubMed  Google Scholar 

  20. Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol. 2003;18(10):986–91 [Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  21. Barnadas G. Preparing for parenteral nutrition therapy at home. Am J Health Syst Pharm. 1999;56(3):270–2 [Review].

    CAS  PubMed  Google Scholar 

  22. Awouters F, Niemegeers CJ, Janssen PA. Pharmacology of antidiarrheal drugs. Annu Rev Pharmacol Toxicol. 1983;23:279–301 [Review].

    Article  CAS  PubMed  Google Scholar 

  23. Nightingale J, Woodward JM. Guidelines for management of patients with a short bowel. Gut. 2006;55 Suppl 4:iv1–12 [Practice Guideline].

    PubMed Central  PubMed  Google Scholar 

  24. Coupar IM, De Luca A. Opiate and opiate antidiarrhoeal drug action on rat isolated intestine. J Auton Pharmacol. 1994;14(1):69–78 [In Vitro Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  25. McGuigan M, Lovejoy Jr FH. Overdose of Lomotil. Br Med J. 1978;1(6118):990 [Letter].

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Cruz-Correa M, Giardiello FM. Lymphocytic and Collagenous Colitis. Curr Treat Options Gastroenterol. 2000;3(3):243–8.

    Article  PubMed  Google Scholar 

  27. Kramer P. Effect of antidiarrheal and antimotility drugs on ileal excreta. Am J Dig Dis. 1977;22(4):327–32 [Clinical Trial Randomized Controlled Trial Research Support, U.S. Gov’t, P.H.S.].

    Article  CAS  PubMed  Google Scholar 

  28. King RF, Norton T, Hill GL. A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust N Z J Surg. 1982;52(2):121–4 [Clinical Trial Comparative Study].

    Article  CAS  PubMed  Google Scholar 

  29. Ladefoged K, Christensen KC, Hegnhoj J, Jarnum S. Effect of a long acting somatostatin analogue SMS 201–995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut. 1989;30(7):943–9 [Clinical Trial Controlled Clinical Trial Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol. 2001;96(5):1494–8 [Clinical Trial Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.].

    Article  CAS  PubMed  Google Scholar 

  31. Harris AG, O’Dorisio TM, Woltering EA, Anthony LB, Burton FR, Geller RB, et al. Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel. Dig Dis Sci. 1995;40(7):1464–73 [Consensus Development Conference Research Support, Non-U.S. Gov’t Review].

    Article  CAS  PubMed  Google Scholar 

  32. McDoniel K, Taylor B, Huey W, Eiden K, Everett S, Fleshman J, et al. Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome. JPEN J Parenter Enteral Nutr. 2004;28(4):265–8 [Case Reports].

    Article  PubMed  Google Scholar 

  33. Buchman AL, Fryer J, Wallin A, Ahn CW, Polensky S, Zaremba K. Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. JPEN J Parenter Enteral Nutr. 2006;30(6):487–91 [Research Support, N.I.H., Extramural].

    Article  CAS  PubMed  Google Scholar 

  34. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology. 2003;124(2):293–302 [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  35. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology. 1997;113(4):1074–81 [Clinical Trial Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.].

    Article  CAS  PubMed  Google Scholar 

  36. Jeppesen PB. Teduglutide for the treatment of short bowel syndrome. Drugs Today (Barc). 2013;49(10):599–614 [Review].

    CAS  Google Scholar 

  37. Vipperla K, O’Keefe SJ. Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects. Expert Rev Gastroenterol Hepatol. 2013;7(8):683–7.

    Article  CAS  PubMed  Google Scholar 

  38. Storr M. Short bowel syndrome. GLP-2 analog teduglutide. Med Monatsschr Pharm. 2013;36(9):343–5.

    CAS  PubMed  Google Scholar 

  39. Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O’Keefe SJ, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology. 2012;143(6):1473–81. [Clinical Trial, Phase III Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. e3.

    Article  CAS  PubMed  Google Scholar 

  40. O’Keefe SJ, Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B. Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure. Clin Gastroenterol Hepatol. 2013;11(7):815–23. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. e1-3.

    Article  PubMed  Google Scholar 

  41. Minneci PC. Intestinal transplantation: an overview. Pathophysiology. 2014;21:119–22.

    Article  PubMed  Google Scholar 

  42. Services CfMaM. Department of Health and Human Services. Meeting your medicare needs. [guideline development]. 2014. [cited 1 Feb 2014]; Available from: http://apps.ngsmedicare.com/applications/Content.aspx?DOCID=20493&CatID=3&RegID=51&ContentID=34464.

  43. Abu-Elmagd K, Reyes J, Todo S, Rao A, Lee R, Irish W, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998;186(5):512–25. [Research Support, U.S. Gov’t, P.H.S.]; discussion 25–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Health Quality Ontario. Small bowel transplant: an evidence-based analysis. Ont Health Technol Assess Ser. 2003;3(1):1–72.

    Google Scholar 

  45. Farmer DG, McDiarmid SV, Winston D, Yersiz H, Cortina G, Dry S, et al. Effectiveness of aggressive prophylactic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation. Transplant Proc. 2002;34(3):948–9 [Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

    Jithinraj Edakkanambeth Varayil MD

  2. Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA

    Ryan T. Hurt MD, PhD

Authors
  1. Jithinraj Edakkanambeth Varayil MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan T. Hurt MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryan T. Hurt MD, PhD .

Editor information

Editors and Affiliations

  1. Division of Vascular and Endovascular Therapy, Mayo Clinic Gonda Vascular Center, Rochester, Minnesota, USA

    Gustavo S. Oderich

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Varayil, J.E., Hurt, R.T. (2015). Medical Management of Short Bowel Syndrome and Nutritional Support. In: Oderich, G. (eds) Mesenteric Vascular Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1847-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1847-8_21

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1846-1

  • Online ISBN: 978-1-4939-1847-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation